EKSO vs MIGI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EKSO Captures Institutional Edge (2โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ekso Bionics Holdings, Inc. Common Stock (EKSO) driven by superior Growth & Margin, Momentum & Technical while MIGI counters with relative strength in Valuation. Fundamentally, EKSO trades at N/M Forward P/E with -119.7% operating margin (-38.3% YoY revenue) versus MIGI at 5.5x Forward P/E and -456.2% operating margin (-78.5% YoY). In options structure, EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MIGI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EKSO | MIGI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $42.0M | $23.0M | Larger Scale | EKSO |
| Trailing P/E Ratio Valuation | N/M | 5.5x | Lower Multiple | MIGI |
| Forward P/E Ratio Valuation | N/M | 5.5x | Lower Multiple | MIGI |
| Revenue Growth (YoY) Growth | -38.3% | -78.5% | Higher Growth | EKSO |
| Operating Margin (TTM) Profitability | -119.7% | -456.2% | Higher Margin | EKSO |
| Net Profit Margin Profitability | -91.4% | -59.5% | Higher Margin | MIGI |
| Return on Equity (ROE) Capital Efficiency | -107.6% | -461.2% | Higher ROE | EKSO |
| 52-Week Range Position Momentum | 87% ($0โ$14) | 28% ($0โ$16) | Stronger Trend | EKSO |
| Beta / 30D Volatility Risk Regime | 2.16ฮฒ ยท 76% Vol | 13.79ฮฒ ยท 314% Vol | Lower Realized Risk | EKSO |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 56.4 / 100 (HOLD) | Higher Composite | EKSO |